| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1ed0faa8a366a7d23cba50510e9e4ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25318c7eb23be1bf0eeb56869c8a91ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8cee6cf94125415a7e7c3ee493d35d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f790e0fa57e652aa994a7cd44c94dbd3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 |
| filingDate |
2013-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_801789eb6832511a001de8cf730819f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d20165043f3494800adce2ff4d7c08e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91bde39b9841d5c45a88bd94908adec9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3267b17fefcb22b91886208f0888983 |
| publicationDate |
2015-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015139980-A1 |
| titleOfInvention |
Detectors of serum biomarkers for predicting ovarian cancer recurrence |
| abstract |
Polypeptide marker antigens for detecting the presence of autoantibody biomarkers associated with ovarian cancer recurrence, each of the polypeptide marker antigens binding specifically to at least one autoantibody marker. An antibody binding assay for detecting the presence of autoantibody biomarkers associated with ovarian cancer recurrence, and methods for performing the assay. Methods for determining ovarian cancer recurrence in an ovarian cancer patient. A method for isolating antibodies specific for ovarian cancer by their affinity to the polypeptide marker antigens, and antibodies isolated by that method. |
| priorityDate |
2012-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |